EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum 25-Hydroxyvitamin D Status and Vitamin D Supplements Use Are Not Associated with Low Back Pain in the Large UK Biobank Cohort

Sha Sha iD, Li-Ju Chen, Hermann Brenner iD, Ben Schöttker iD

Nutrients · 2024

DOI: 10.3390/nu16060806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Sha Sha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: Low Back Pain, Vitamin D Deficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, UK Biobank Resource, National Health Service (NHS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Longitudinal studies assessing the association of vitamin D deficiency, defined by serum 25-hydroxyvitamin D levels < 30 nmol/L, and vitamin D supplement (VDS) use with low back pain (LBP) are sparse. This investigation assessed the cross-sectional and longitudinal association of vitamin D status and VDS use with LBP among 135,934 participants from the UK Biobank cohort. Approximately 21.6% of the participants had vitamin D deficiency, while only 4% regularly took VDS. In the month before study enrollment, 3.8% of the population reported experiencing LBP. An additional 3.3% of the population were diagnosed with LBP by their general practitioners for the first time during a median follow-up of 8.5 years. Vitamin D deficiency and VDS use were cross-sectionally associated with LBP in age- and sex-adjusted models, but these associations were not evident in comprehensively adjusted models. In longitudinal analyses, both vitamin D deficiency and VDS use were not associated with LBP in any model after correction for multiple testing. In conclusion, not unexpectedly due to the fact that LBP is multifactorial, our findings provide no evidence for the role of the vitamin D status in the etiology of LBP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Low Back PainVitamin D DeficiencyHumansCross-Sectional StudiesBiological Specimen BanksUK BiobankVitamin DVitaminsDietary SupplementsCalcifediol

Stichwörter der Autor:innen

25-hydroxyvitamin Dlow back painreal-world evidencevitamin D supplement use

Substanzen

25-hydroxyvitamin DVitamin DVitaminsCalcifediol

Autor:innen und Institutionen

  • Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120 Heidelberg, Germany.
  • Faculty of Medicine, University of Heidelberg, Im Neuenheimer Feld 672, 69120 Heidelberg, Germany.
  • Division of Preventive Oncology, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 581, 69120 Heidelberg, Germany.

ORCID-Profile: Sha Sha, Hermann Brenner, Ben Schöttker

Förderung

  • Wellcome Trust
  • UK Biobank Resource
  • National Health Service (NHS)
  • Chinese Scholarship Council

Zitieren

APA

Sha, S., Chen, L. J., Brenner, H., & Schöttker, B. (2024). Serum 25-Hydroxyvitamin D Status and Vitamin D Supplements Use Are Not Associated with Low Back Pain in the Large UK Biobank Cohort. Nutrients. https://doi.org/10.3390/nu16060806

Vancouver

Sha S, Chen LJ, Brenner H, Schöttker B. Serum 25-Hydroxyvitamin D Status and Vitamin D Supplements Use Are Not Associated with Low Back Pain in the Large UK Biobank Cohort. Nutrients. 2024. doi:10.3390/nu16060806

BibTeX
@article{Sha2024,
  author = {Sha, Sha and Chen, Li-Ju and Brenner, Hermann and Schöttker, Ben},
  title = {Serum 25-Hydroxyvitamin D Status and Vitamin D Supplements Use Are Not Associated with Low Back Pain in the Large UK Biobank Cohort},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16060806}
}
Kostenlos starten →